https://www.avient.com/sites/default/files/resources/PolyOne%25202012%2520Annual%2520Report.pdf
Off-Balance Sheet Arrangements We have no off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K other than the SunBelt debt guarantee described previously in the Guarantee of Indebtedness of Others section.
Amounts invested in our foreign operations are translated into U.S. dollars at the exchange rates in effect at the balance sheet date.
Derivative financial instruments are accounted for at fair value and recognized as assets or liabilities in the Consolidated Balance Sheets.
https://www.avient.com/products/vinyl-formulations/vinyl-powder-coating-and-dip-molding/core-vinyl-powder-coating-formulations
A balance of fusion characteristics and physical properties
https://www.avient.com/company/sustainability/sustainability-report/products/markets/protective-materials
This innovation utilizes the mass balance approach and further reduces our reliance on fossil fuel based resources.
https://www.avient.com/products/vivo-formulations-healthcare/neu-custom-capabilities
NEU™ Custom Capabilities offer a balance of material science expertise and technical application development to manufacture a short-term in-vivo catheter material that meets the formulation specifications for your medical application when performance and speed to market are paramount.
https://www.avient.com/news/reduce-material-costs-and-improve-processing-new-foaming-fluoropolymer-wire-insulation-technology
This new technology balances all three performance requirements and boosts productivity without the need for additional equipment investment.”
https://www.avient.com/products/vinyl-formulations
Our full range of plastisols and powder coating formulations offer a balance of both cost efficiency and performance.
Find
Technical Data Sheets
See List
https://www.avient.com/sites/default/files/2024-03/AS-FILED EF20024640 Avient Corp ARS.pdf
Amounts invested in our foreign operations are translated into U.S. dollars at the exchange rates in effect at the balance sheet date.
The resulting translation adjustments are recorded as a component of Accumulated other comprehensive (loss) income in the Shareholders’ equity section of the accompanying Consolidated Balance Sheets.
The fair value of derivative financial instruments recognized in the Consolidated Balance Sheets as of December 31, 2023 and 2022 is as follows: (In millions) Balance Sheet Location 2023 2022 Cross Currency Swaps (Net Investment Hedge) Other non-current liabilities $ 199.1 $ 68.6 63 AVIENT CORPORATION ITEM 9.
https://www.avient.com/sites/default/files/resources/POL%2520Credit%2520Suisse%2520IR%2520Presentation%2520w%2520non-GAAP%25209%252017%25202013.pdf
EPS: $1.00 $0.54 $0.68 $0.30 $0.45 $0.60 $0.75 H1'12 H1'13 Adjusted EPS $101.0 $132.6 $50.0 $100.0 $150.0 H1'12 H1'13 Adjusted Operating Income (millions) +31% $68.6 $97.7 $50.0 $75.0 $100.0 H1'12 H1'13 Specialty Operating Income (millions) First Half 2013 Financial Highlights • Adjusted EPS increased 26% over prior year first half • Operating Income expanded 31% versus first half 2012 • Specialty operating income up 42% • Revenue grew 22% versus 1H ‘12 • Portfolio transformation activities Completed acquisition of Spartech Divested non-core Resin business +26% +42% Page 12 • Significant Debt Maturities $ 1,010 Other Debt 21 • Total Debt at 6/30/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 1.9x • Net Debt / EBITDA = 2.1x*(tax adjusted) $392 310 $702 $1,031 392 $639 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of June 30, 2013 ($ millions) Page 13 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM for taxes on resin gain Debt Maturities & Liquidity Summary – 6/30/13 Cash Balance = $392M Net Debt / EBITDA* = 1.9x • Repurchased ~3.0M shares YTD in 2013 • 17 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions • North American manufacturing alignment Acquisitions *TTM 6/30/2013 Use of Cash Page 14 Why Invest In PolyOne?
Average Debt Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average PolyOne Debt $ 705.8 $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 840.9 Average Equity Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average PolyOne shareholders’ equity $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 745.7 Platform sales and operating income (OI) H1 2012*** H1 2013*** H1 2013**** Global Specialty Engineered Materials Sales $ 280.9 $ 352.0 $ 285.1 Global Color, Additives and Inks Sales 413.9 434.7 409.2 Designed Structures & Solutions Sales - 240.4 - Specialty Platform Sales $ 694.8 $ 1,027.1 $694.3 Performance Products and Solutions Sales 336.0 336.7 317.5 PolyOne Distribution Sales 533.6 543.1 543.1 Corporate and Eliminations (62.3) (68.2) (68.2) Total Sales $ 1,502.1 $ 1,838.7 $ 1,486.7 Global Specialty Engineered Materials OI $ 24.6 $ 32.5 $ 31.2 Global Color, Additives and Inks OI 44.0 54.7 52.0 Designed Structures & Solutions OI - 10.5 - Specialty Platform OI $ 68.6 $ 97.7 $ 83.2 Performance Products and Solutions OI 19.3 27.5 25.7 PolyOne Distribution OI 33.4 33.1 33.1 Corporate and eliminations (20.3) (25.7) (20.3) Special items in OI (20.3) (11.4) (20.3) Operating income - GAAP $ 80.7 $ 121.2 $ 101.4 Special items in OI 20.3 11.4 20.3 Operating income adjusted $ 101.0 $ 132.6 $ 121.7 Global Specialty Engineered Materials - OI % of sales 8.8% 9.2% 10.9% Global Color, Additives and Inks - OI % of sales 10.6% 12.6% 12.7% Designed Structures & Solutions - OI % of sales - 4.4% - Specialty platform - OI % of sales 9.9% 9.5% 12.0% PP&S operating - OI % of sales 5.7% 8.2% 8.1% Distribution OI - % of sales 6.3% 6.1% 6.1% PolyOne OI adjusted - % of sales 6.7% 7.2% 8.2% Reconciliation to Condensed Consolidated Balance Sheets H1 2013 Short-term debt and current portion of long-term debt $ 8.7 Long-term debt 1,022.5 Less cash and cash equivalents (392.4) Specialty Platform Gross Margin Percentage 2006Y* Q2 2013**** Global Specialty Engineered Materials Sales $ 345.3 $ 143.5 Global Color, Additives and Inks Sales 531.8 207.5 Specialty Platform Sales $ 877.1 $ 351.0 Global Specialty Engineered Materials Gross Margin $ 41.6 $ 37.3 Global Color, Additives and Inks Gross Margin 83.6 71.8 Specialty Platform Gross Margin $ 125.2 $ 109.1 Specialty Platform Gross Margin Percentage 14.3% 31.1% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
Credit Suisse September 2013 Investor Presentation non-GAAP v2.pdf Reconciliation to Condensed Consolidated Balance Sheets
https://www.avient.com/sites/default/files/resources/POL%2520CFA%2520IR%2520Presentation%2520w%2520non%2520GAAP%252011%252019%25202013.pdf
EPS: $1.00 $0.28 $0.36 $0.20 $0.30 $0.40 Q3 '12 Q3 '13 Adjusted EPS $51.8 $72.4 $40.0 $60.0 $80.0 Q3 '12 Q3 '13 Adjusted Operating Income (millions) 40% $31.7 $55.3 $20.0 $40.0 $60.0 Q3 '12 Q3 '13 Specialty Operating Income (millions) Q3 2013 Financial Highlights • Adjusted EPS increased 29% over prior year • Adjusted Operating Income expanded 40% versus Q3 2012 • Specialty operating income up 74% • Revenue increases 43% versus Q3 2012 • Portfolio transformation activities Completed acquisition of Spartech Divested non-core Resin Business 29% 74% Page 11 Significant Debt Maturities Other Debt Total Debt at 9/30/13 Less: Cash Net Debt Available Liquidity Cash ABL Availability Total Liquidity Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of September 30, 2013 ($ millions) Page 12 Coupon Rates: 7.500% 7.375% 5.250% Debt Maturities & Liquidity Summary – 9/30/13 $ 965 22 $ 987 323 $ 664 $ 323 308 $631 *TTM 9/30/2013 Cash Balance = $323M Net Debt / EBITDA* = 1.9x • Repurchased 3.8M shares YTD in 2013 • 16.2 million shares are available for repurchase under the current authorization • Repurchased $45 million, par value, of higher coupon bonds YTD Share/Bond Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • North American manufacturing alignment • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions Acquisitions *TTM 9/30/2013 Use of Cash Page 13 Why Invest In PolyOne?
Average Debt Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Average PolyOne Debt $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 987.7 $ 897.3 Average Equity Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Average PolyOne shareholders’ equity $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 996.6 $ 824.1 Reconciliation to Condensed Consolidated Balance Sheets YTD 2013 Short-term debt and current portion of long-term debt $ 9.9 Long-term debt 977.8 Less cash and cash equivalents (322.8) Net debt $ 664.9 Adjusted EBITDA Q4 2012 Q1 2013 Q2 2013 Q3 2013 Total PolyOne Income before income taxes $ (1.1) $ 15.7 $ 62.9 $ 38.8 $ 116.3 PolyOne Interest expense, net 13.7 15.6 16.6 16.0 61.9 PolyOne Depreciation and amortization 15.5 19.0 25.8 30.3 90.6 PolyOne Special items in EBITDA 26.5 27.7 (5.2) 11.2 60.2 PolyOne Adjusted EBITDA 54.6 78.0 100.1 96.3 329.0 Pro forma Spartech EBITDA 14.7 11.2 - - 25.9 Pro forma EBITDA $ 69.3 $ 89.2 $ 100.1 $ 96.3 $ 354.9 CFA Society Cleveland �Midwest Investment Conference 2013��PolyOne Investor Presentation �November 19, 2013� Forward – Looking Statements Use of Non-GAAP Measures Strategy and Execution Drive Results PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Innovation Drives Earnings Growth We are Experts in Polymer Science and Formulation Positioned for Strong Growth Q3 2013 Financial Highlights Debt Maturities & Liquidity Summary – 9/30/13 Use of Cash Why Invest In PolyOne?
ADP35C9.tmp Reconciliation to Condensed Consolidated Balance Sheets
https://www.avient.com/sites/default/files/resources/PolyOne%2520Investor%2520Presentation%2520Jefferies%25202013%2520Global%2520Industrial%2520Conference_Posting.pdf
EPS: $1.00 $0.54 $0.68 $0.30 $0.45 $0.60 $0.75 H1'12 H1'13 Adjusted EPS $101.0 $132.6 $50.0 $100.0 $150.0 H1'12 H1'13 Adjusted Operating Income (millions) +31% $68.8 $97.7 $50.0 $75.0 $100.0 H1'12 H1'13 Specialty Operating Income (millions) First Half 2013 Financial Highlights • Adjusted EPS increased 26% over prior year first half • Operating Income expanded 31% versus first half 2012 • Specialty operating income up 42% • Revenue grew 22% versus 1H ‘12 • Portfolio transformation activities Completed acquisition of Spartech Divested non-core Resin business +26% +42% Page 12 • Significant Debt Maturities $ 1,010 Other Debt 21 • Total Debt at 6/30/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 1.9x* • Net Debt / EBITDA = 2.1x*(tax adjusted) $392 310 $702 $1,031 392 $639 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of June 30, 2013 ($ millions) Page 13 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM Debt Maturities & Liquidity Summary – 6/30/13 Cash Balance = $392M Net Debt / EBITDA* = 1.9x • Repurchased ~3.0M shares YTD in 2013 • 17 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions • North American manufacturing alignment Acquisitions *TTM 6/30/2013 Use of Cash Page 14 Why Invest In PolyOne?
Average Debt Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average PolyOne Debt $ 705.8 $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 840.9 Average Equity Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average PolyOne shareholders’ equity $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 745.7 Platform sales and operating income (OI) H1 2012*** H1 2013*** Global Specialty Engineered Materials Sales $ 280.9 $ 352.0 Global Color, Additives and Inks Sales 413.9 434.7 Designed Structures & Solutions Sales - 240.4 Specialty Platform Sales 694.8 1,027.1 Performance Products and Solutions Sales 336.0 336.7 PolyOne Distribution Sales 533.6 543.1 Corporate and Eliminations (62.3) (68.2) Total Sales $ 1,502.1 $ 1,838.7 Global Specialty Engineered Materials OI $ 24.6 $ 32.5 Global Color, Additives and Inks OI 44.0 54.7 Designed Structures & Solutions OI - 10.5 Specialty Platform OI $ 68.6 $ 97.7 Performance Products and Solutions OI 19.3 27.5 PolyOne Distribution OI 33.4 33.1 Corporate and eliminations (20.3) (25.7) Special items in OI (20.3) (11.4) Operating income - GAAP $ 80.7 $ 121.2 Special items in OI 20.3 11.4 Operating income adjusted $ 101.0 $ 132.6 Global Specialty Engineered Materials - OI % of sales 8.8% 9.2% Global Color, Additives and Inks - OI % of sales 10.6% 12.6% Designed Structures & Solutions – OI % of sales - 4.4% Specialty platform OI % of sales 9.9% 9.5% PP&S operating OI % of sales 5.7% 8.2% Distribution OI % of sales 6.3% 6.1% PolyOne OI adjusted, % of sales 6.7% 7.2% Reconciliation to Condensed Consolidated Balance Sheets H1 2013 Short-term debt and current portion of long-term debt $ 8.7 Long-term debt 1,022.5 Less cash and cash equivalents (392.4) Specialty Platform Gross Margin Percentage 2006Y* Q2 2013**** Global Specialty Engineered Materials Sales $ 345.3 $ 143.5 Global Color, Additives and Inks Sales 531.8 207.5 Specialty Platform Sales $ 877.1 $ 351.0 Global Specialty Engineered Materials Gross Margin $ 41.6 37.3 Global Color, Additives and Inks Gross Margin 83.6 71.8 Specialty Platform Gross Margin $ 125.2 $ 109.1 Specialty Platform Gross Margin Percentage 14.3% 31.1% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
August 13 - Jefferies 2013 Investor Presentation non-GAAP v2 (2).pdf Reconciliation to Condensed Consolidated Balance Sheets